-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 23, Hisun Pharmaceutical issued an announcement stating that the company had recently received the "Drug Registration Certificate" for valsartan tablets approved and issued by the State Drug Administration
.
According to the announcement, valsartan tablets are suitable for the treatment of mild to moderate essential hypertension
.
The company's valsartan tablets were approved by the State Food and Drug Administration according to the new 4 categories, and they were deemed to have passed the consistency evaluation
.
On May 20, 2020, the State Food and Drug Administration accepted the company's application for drug registration for valsartan tablets
.
So far, the company has invested approximately RMB 13.
92 million in the drug R&D project